# A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male Volunteers

> **NCT00951522** · PHASE1 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 15 (estimated)

## Conditions studied

- Cystic Fibrosis
- Mucociliary Clearance
- Airway Hydration

## Interventions

- **DRUG:** GS-9411
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00951522
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2009-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00951522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00951522, "A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00951522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*